Complex genetic disorders such as depression likely exhibit epistasis, but neural mechanisms of such gene-gene interactions are incompletely understood. 5-HTTLPR and BDNF VAL66MET, functional polymorphisms of the serotonin (5-HT) transporter (SLC6A4) and brain-derived neurotrophic factor (BDNF) gene, impact on two distinct, but interacting signaling systems, which have been related to depression and to the modulation of neurogenesis and plasticity of circuitries of emotion processing. Recent clinical studies suggest that the BDNF MET allele, which shows abnormal intracellular trafficking and regulated secretion, has a protective effect regarding the development of depression and in mice of social defeat stress. Here we show, using anatomical neuroimaging techniques in a sample of healthy subjects (n = 111), that the BDNF MET allele, which is predicted to have reduced responsivity to 5-HT signaling, protects against 5-HTTLPR S allele-induced effects on a brain circuitry encompassing the amygdala and the subgenual portion of the anterior cingulate (rAC). Our analyses revealed no effect of the 5-HTTLPR S allele on rAC volume in the presence of BDNF MET alleles, whereas a significant volume reduction (P < 0.001) was seen on BDNF VAL/VAL background. Interacting genotype effects were also found in structural connectivity between amygdala and rAC (P = 0.002). These data provide in vivo evidence of biologic epistasis between SLC6A4 and BDNF in the human brain by identifying a neural mechanism linking serotonergic and neurotrophic signaling on the neural systems level, and have implications for personalized treatment planning in depression.
Introduction
Depression is among the four leading causes of disease burden throughout the world and is associated with medical morbidity and mortality across the lifespan. 1 In the complex genetic architecture of depression, variations impacting on the serotonin (5-HT) system have been implicated prominently. [2] [3] [4] [5] [6] [7] Specifically, human carriers of the S allele of 5-HTTLPR have been reported to have increased anxiety-related temperamental traits, 5, 8 an elevated risk of depression, 6 decreased gray matter volume of amygdala and anterior cingulate (rAC) 7 and reduced functional coupling between those structures 7 leading to increased amygdala reactivity. 3, 7 These genotyperelated alterations in anatomy and function of an amygdala-cingulate feedback circuitry critical for emotional regulation 9 have been implicated in a developmental, systems-level mechanism underlying emotional reactivity and genetic susceptibility for anxiety and depression. 7 Indeed, association of 5-HTTLPR with activity within this circuitry has been much more consistent than with the clinical diagnosis of mood and anxiety disorders or with related temperamental measures. [10] [11] [12] Animal experiments with neonatal stress paradigms 13 and genetic engineering suggest that altered 5-HT signaling during a critical early developmental period 14 can cause a lifelong pattern of anxious behavior. 15 The molecular mechanism of this serotonergic effect during development is largely unknown, but recent studies indicate that neurotrophic factors, which mediate changes in synaptic architecture in response to 5-HT signaling, [16] [17] [18] may be involved.
Among neurotrophins, a particularly attractive candidate molecule is brain-derived neurotrophic factor (BDNF), whose expression is partly mediated via the transcription factor cAMP response element-binding protein, which is responsive to 5-HT-induced intracellular signaling. 19 Substantial evidence suggests that BDNF promotes the development and function of serotonergic neurons and mood-related effects. 17, [19] [20] [21] [22] [23] Studies of genetic association of BDNF with depression have produced mixed results. 24 Curiously, the positive genetic associations of BDNF to mood disorders have usually, but not consistently, found the VAL allele of VAL66MET BDNF to be the risk allele, which is counterintuitive given that the MET allele is associated with abnormal intracellular sorting and regulated secretion of BDNF and abnormal hippocampal structure and function. 25, 26 Further evidence for a complex role of BDNF in depression comes from preclinical studies investigating genetic disruption of BDNF pathways, which suggest that BDNF mediates biological consequences of social defeat stress 27 as well as antidepressive effects, 24 including most treatment modalities such as electroconvulsive therapy, 16 drug treatment with 5-HT re-uptake inhibitors and enhancers 16, 18 as well as lithium. 28 These data implicating a biological interaction of BDNF and 5-HT signaling suggest a molecular cascade that could support epistasis between 5-HTTLPR and BDNF VAL66MET in biasing brain development toward susceptibility for depression. The possibility of epistasis between SLC6A4 and BDNF has been explored to a limited degree in animals genetically engineered to be hypomorphic at both genes, 17, 21, 22, 29 indicating that a loss of BDNF exacerbates brain monoamine deficiencies and increases stress abnormalities in SLC6A4 knockout mice. Human data are limited and contradictory. Two studies of depressive symptoms, one in children 30 and one in elderly Koreans 31 reported a significant three-way interaction between environmental adversity, VAL66MET BDNF and 5-HTTLPR, but did not find any gene Â gene interaction. Interestingly, BDNF MET and homozygote 5-HTTLPR S allele carriers had highest depression scores in those studies, although most studies find what appears to be the opposite 17 and have suggested a protective effect of the BDNF MET allele for anxiety, 32,33 depression 34-37 and bipolar disorder. 38, 39 Similarly, a study reported enhanced response to lithium 28 in 5-HTTLPR S allele carriers with BDNF MET alleles.
While data at the level of clinical phenotype are inconsistent, advances in imaging genetics 40 and the availability of large human samples make it now feasible to study the effects of likely interacting polymorphisms, 23, [41] [42] [43] such as 5-HTTLPR and BDNF VAL66MET and their developmental impact on mood-related circuitries in the living human brain. Here, we report the results of a human in vivo study, exploring biologic epistasis of 5-HTTLPR and BDNF VAL66MET in a large Caucasian sample of healthy subjects without any lifetime history of psychiatric illness. 7 The study of psychiatrically healthy individuals allows for an analysis of gene-gene interactions independent of potentially modifying effects of illness, treatment and associated factors. Previous work has shown that the S allele of 5-HTTLPR affects the integrity and presumably development of a neural circuitry linking amygdala and rAC. 7 We used a structural neuroimaging strategy to identify developmental effects of BDNF VAL66MET and 5-HTTLPR on this circuitry analogous to our previous work. 7 We predicted that the effect on brain structure of alleles at 5-HTTLPR would vary depending on BDNF VAL66-MET background as suggested by preclinical studies. 17, 21 Specifically, we hypothesized that the BDNF MET allele, because it is less sensitive to stimuli that induce BDNF secretion than are VAL alleles, [25] [26] [27] would lessen the developmental impact of the 5-HTTLPR S allele on amygdala-rAC circuitry, making it a protective factor in the risk architecture of depression through its biologic interaction with 5-HTTLPR.
Materials and methods

Subject recruitment and demographics
Subjects were culled from a larger population after careful screening 7 to ensure they were free of any lifetime history of psychiatric or neurological illness, psychiatric treatment, or drug or alcohol abuse (see Supplementary Table 2 ). Only Caucasians of European ancestry were studied to avoid stratification artifacts. In 114 subjects, 5-HTTLPR genotype data were available. This is the same sample reported previously in a 5-HTTLPR-restricted analysis. 7 The current study encompassed a slightly smaller sample since in three subjects no BDNF VAL66MET genotype data were available. Subjects gave written informed consent and participated in the study according to the guidelines of the National Institute of Mental Health Institutional Review Board. Finally, structural magnetic resonance imaging from the entire sample of 111 subjects were used and customized templates were created as described elsewhere.
7,44
Genotyping Genotyping for the 5-HTTLPR and BDNF VAL66MET polymorphisms was performed as described previously. 7,44. As an active genetic control, we studied a well-characterized common functional polymorphism in COMT (VAL(108/158)MET), encoding for catecholamine-O-methyltransferase. This variant is useful as a stringent control as it is associated with prefrontal and hippocampal cognitive function, functional brain activation, 45, 46 cortical regulation of emotional networks and mood-related temperamental measures, 47 but has not been associated with trophic interactions with the 5-HT transporter. Identical to our previous studies, our sample was genotyped with a genomic control panel of 100 unlinked SNP loci to survey for occult genetic stratification 7,44 between 5-HTTLPR and BDNF VAL66MET genotype groups and showed no indication of significant stratification effects (available upon request). Details on procedures and (lacking) effects of a recently described functional polymorphism of the 5-HTTLPR L allele within this sample can been found in the Supplementary information (see note 1, Supplementary Figure 4 and Supplementary Table 1 ). There was no correlation of alleles in BDNF and in 5-HTTLPR in our sample.
Structural image processing
Three-dimensional structural magnetic resonance imaging scans were acquired and pre-processed using algorithms of previous studies. 7, 44 Briefly, images were acquired on a 1.5 T GE scanner (Milwaukee, WI, USA) using a T1-weighted SPGR sequence (TR/TE/NEX 24/ 5/1, flip angle 451, matrix size 256Â 256, FOV 24 cm Â 24 cm) with 124 sagittal slices (0.94 mm Â 0.94 mm Â 1.5 mm resolution) and pre-processed using an optimized voxel-based morphometry protocol with customized templates. 7, 44 Resulting gray matter images were smoothed with a 12 mm Gaussian kernel prior to statistics.
Volumetric image analysis
Images were scaled by total gray matter volume and then transformed into the AFNI format (http:// afni.nimh.nih.gov/afni). Statistical analysis was performed on a Linux workstation (RedHat Enterprise) using MATLAB 6.52SP2 (MathWorks, Natick, MA, USA) and a custom-written statistical toolbox implementing an unbalanced four-way random effects analysis of covariance (ANCOVA) (http://afni.nimh.-nih.gov/sscc/gangc).
Specification of the design matrix. We performed an ANCOVA with three categorizing between-subject factors: gender, 5-HTTLPR (S carriers and LL homozygotes) and BDNF VAL66MET (MET carriers and VAL homozygotes). Each factor had two levels (gender or allele subgroups), and each of 111 subjects was nested under one of the resulting eight (2 Â 2 Â 2) groups. The model was by definition unbalanced because of unequal number of subjects with specific genotype combinations across groups (representing unequal distribution of genotypes in Caucasian populations). Subjects were included as an extra factor (random), ensuring that random effects across subjects were properly modeled, resulting in an unbalanced four-way random effects ANCOVA with three fixed and one random factor. Orthogonalized age data were included as covariates as detailed elsewhere. 7 Structural covariance analysis Our methods to estimate 'structural covariance' have been previously described. 48 By correlating volume in a region of interest (ROI) with regional volumes across subjects, this approach identifies areas which have regional volume that is significantly (positively or negatively) correlated with the target area across subjects, providing a putative indirect measure of anatomical connectivity that has been shown to correspond to neuroanatomical data on regional connectivity. 7 The summed volume in the amygdala ROI (taken from our previous work 7 ) in standardized space was computed by adding the local volumes in all voxels in the ROI and used as a covariate of interest in a random-effects general ANCOVA as described before. 7 We applied a perigenual ROI derived from our previous work 7 on the structural impact of 5-HTTLPR genetic variation and assessed regional gray matter volume changes between genotype groups or changes in covariation with amygdala between genotype groups using appropriate t-contrasts after small volume correction for the ROI. For all imaging analyses, false discovery rate estimations were utilized to correct for multiple comparisons within the ROI and a probability of 0.05 was considered as being significant.
Creation of surface maps and plots
For visualization, t-statistics maps were overlaid on a standard surface (Colin Holmes' brain surface) using the SUMA package (http://afni.nimh.nih.gov/afni/ suma). Details of the procedure have been published previously. Plots represent extracted relative regional volumes at cluster peak locations as reported in Figure 2 . For structural covariance, the mean corrected product of regional volumes in the amygdala and perigenual anterior cingulate cortex (pAC) was used. Extracted values were normalized to mean values relative to the LL genotype of 5HTTLPR using SPSS 11.0 (SPSS Inc., Chicago, IL, USA) for Mac OSX (Apple Computers Inc., Cupertino, CA, USA) resulting in percent changes relative to the other genotype combinations.
Results
Epistasis and morphometry
To test for epistatic effects on the morphology of limbic circuitry, consistent with neurodevelopmental studies of animals with altered 5-HT and BDNF function, [13] [14] [15] 21, 22 we used 'optimized' voxel-based morphometry, a sophisticated and automated method designed to measure relative gray matter volume changes with sufficient sensitivity to detect effects of genetic variation. 7, 44 Consistent with our hypothesis we found that the previously described 7 S allele effect of 5-HTTLPR on the pAC and amygdala was significantly modulated by BDNF genotype (see Figure 1 and Supplementary Figures 1 and 2) .
In comparison to BDNF VAL/VAL genotype, BDNF MET carriers showed a diminished 5-HTTLPR S allele effect in comparison to 5-HTTLPR LL genotype (see Figure 2 and Table 1 ), which was also present in an interaction analysis between SLC6A4 and BDNF (see Figure 3 , Table 1 , as well as Supplementary Figure 3) , analogous to preclinical data reporting epistatic effects of SLC6A4 and BDNF. 21 This effect was independent of age and gender and was not impacted by a newer triallelic classification Table 1 ). While this analysis was based upon a specific a priori hypothesis regarding a neural circuitry encompassing amygdala and pAC based on earlier work, 7 we also performed a post hoc analysis of three control regions in the brain (hippocampus, dorsolateral prefrontal cortex and striatum) with the goal of investigating the circuitry specificity of this finding. In accordance with our primary hypothesis, we found that this epistatic effect only affected the pAC and not any of those three control regions (see Supplementary Figures 5-7) .
Structural volume changes were more pronounced in the pAC than in amygdala (see Figure 1 ). Identical to our previous work, 7 the rAC, a structure prominently implicated in depression 49 and in the feedback regulation of amygdala reactivity, was the punctum maximum of observed gray matter volume reductions in 5-HTTLPR S allele carriers with a BDNF VAL/VAL genotype background within the whole brain (see Figure 1 ). Computation of Cohen d effect sizes showed a large effect in VAL homozygotes (d = 0.87, variance explained by genotype 15.8%, P < 0.007), while MET allele carriers showed only a medium effect size (d = 0.34, variance explained by genotype 2.7%, NS), indicating that this observation was not a consequence of differences in group size. For comparison, the main effect for the 5-HTTLPR genotypes alone showed an effect size of d = 0.67, and 10.0% of variance was explained by genotype P < 0.008, while for BDNF the corresponding values were d = 0.34, and 2.8% of variance was explained by genotype, NS.
As a genetic control, we also analyzed regional volume as a function of COMT VAL(108/158)MET genotype, which was available for the 101 participants (see Supplementary Tables 2 and 3 ). While the 5-HTTLPR S allele-associated volume reduction was again highly significant (P < 0.005, analysis of variance) in this slightly smaller subgroup, virtually no difference in the size of this reduction was seen between COMT genotypes, indicating the absence of an epistatic effect with this gene (see Supplementary  Figure 8 ). Epistasis and structural covariance Given the prior anatomical evidence of interconnection between amygdala and pAC, 50 we further examined an indirect measure of anatomical coupling, structural covariance. While this measure does not provide a direct quantification of neuronal connections, such as white matter tracts, it has been shown by us 7 and others 48 to delineate patterns in good agreement with such neuroanatomical connections, and has recently been reported to be disrupted in pathophysiological processes in a set of studies of aging [51] [52] [53] and schizophrenia. 54 Similarly, we originally reported 7 structural connectivity to be reduced in 5-HTTLPR S carriers. In the present study, we found that BDNF genotypes significantly impacted on the 5-HTTLPR S allele effect on structural covariance between amygdala and pAC as predicted (see Figure 4) . Specifically, a comparison within S allele carriers revealed significantly less structural connectivity in BDNF MET allele carriers in comparison to BDNF VAL/VAL genotype (see Table 1 ). A further comparison of a low-risk group for depression (5-HTTLPR L/L genotype and BDNF MET allele carrier) with two 5-HTTLPR S allele carrier groups (BDNF VAL/VAL or MET background) showed that only the high-risk genotypes associated with depression (5-HTTLPR S allele carrier and BDNF VAL/VAL genotype) exhibited a significant decrease of structural covariance between amygdala and pAC, likely reflecting relatively abnormal 'wiring' in the high-risk group (see Table 1 , as well as Supplementary Figure 9 and Supplementary Table 4). (Table 1) . 
Discussion
MET allele of BDNF protects against the adverse effects of 5-HTTLPR S alleles in brain morphometry Our morphometric findings expand on previously reported evidence that development of mood circuitry encompassing amygdala and pAC is genetically modulated by 5-HTTLPR. 7 We have now demonstrated that BDNF VAL66MET interacts in an epistatic manner with 5-HTTLPR, presumably affecting the development and integrity of this mood-related neural system. Since this circuitry is closely linked to the processing of negative emotions 7 and to depression, 49 especially in the presence of adverse life events, 2 our findings are consistent with polygenetic concepts 55 of depression, implicating a specific epistatic effect of the presence of allelic variants of 5-HTTLPR and BDNF. Our data are also consistent with evidence that BDNF mediates neural mechanisms of social defeat stress-related plasticity that may lead to maladaptive behavioral outcomes 27, 56 as well with interactions with environmental adversity that have been reported with the 5-HTTLPR S allele. However, our results underscore the importance of the individual genetic blueprint, since the BDNF MET allele protects against the adverse effects of 5-HTTLPR S alleles in brain, 2, 13 which the ancestral BDNF allele (VAL) potentiates (see Supplementary  Figure 10 ). Hence, we speculate that the BDNF MET allele reduces the impact of the HTTLPR S allele on amygdala-subgenual cingulate circuitry for extinction, leading to increased resilience to environmental adversity 2 and consequently reduced vulnerability to depression. Strikingly, recent results from a variant genetically humanized mouse model support these conclusions by showing that anxiety behavior in animals carrying MET BDNF is unresponsive to 5-HT re-uptake inhibitors, which can be viewed as pharmacological analogs of 5-HTTLPR S alleles. 57 Our results further suggest a biologic mechanism for the seemingly unexpected association of the BDNF VAL allele with mood disorders and may have implications for understanding some of the evolutionary pressures that have worked on both of these genes, which show pronounced variation in allele frequencies in world populations and recent selection effects. 58 In addition to the protective effects of the BDNF MET allele, these findings might be helpful for development of effective personalized treatment plans based on the genetic makeup of individuals. 17 MET allele of BDNF protects against the adverse effects of 5-HTTLPR S alleles on a brain-systems level Similar to our previous work 7 this study also underlines the importance of genetic influence on neural systems as demonstrated with analyses of structural covariance. Observed patterns of structural covariance closely conform to predictions from anatomical connectivity, 48, 59 and data on disrupted structural covariance in aging 51, 53 and schizophrenia 54 also agree with evidence obtained about disturbed anatomical connectivity in these conditions. Although direct proof of anatomical miswiring in subjects vulnerable to depression or even depressive patients will have to come from studies that analyze structural covariance together with methods that directly assess anatomical connections such as diffusion tensor imaging, our data provide evidence that abnormal structural wiring in the analyzed circuitry might in fact be the case. The goal of this research was to identify neural systems mediating the genetic interaction of 5-HTTLPR and BDNF VAL66MET. Our findings do not necessarily establish the usefulness of the imaging measures used here for gene-finding efforts, 40 that is, we do not propose their use as 'endophenotypes' 60 for depression and anxiety, but our findings might contribute to the development of diagnostic vulnerability assessment and treatment plans based on individual genetic variation. 17 To our knowledge, these are the first data showing biologic epistasis in vivo in the human brain in the context of depression and anxiety, which is supported by results from animal studies. 17, 21, 22, 29 
